These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 27432461)
21. Clinico-mycological study of onychomycosis in a tertiary care hospital-A cross-sectional study. Kayarkatte MN; Singal A; Pandhi D; Das S Mycoses; 2020 Jan; 63(1):113-118. PubMed ID: 31642133 [TBL] [Abstract][Full Text] [Related]
23. Mycology of nail disorders. Midgley G; Moore MK; Cook JC; Phan QG J Am Acad Dermatol; 1994 Sep; 31(3 Pt 2):S68-74. PubMed ID: 8077512 [TBL] [Abstract][Full Text] [Related]
24. Comparative analysis of onychomycosis in Puerto Rico using molecular and conventional approaches. Marin-Maldonado F; Pacheco-Torres AL; Gustafson E J Mycol Med; 2023 Aug; 33(3):101412. PubMed ID: 37451067 [TBL] [Abstract][Full Text] [Related]
25. Onychomycosis in Hong Kong. Kam KM; Au WF; Wong PY; Cheung MM Int J Dermatol; 1997 Oct; 36(10):757-61. PubMed ID: 9372350 [TBL] [Abstract][Full Text] [Related]
26. Performance of mycology and histopathology tests for the diagnosis of toenail onychomycosis due to filamentous fungi: Dermatophyte and non-dermatophyte moulds. Lavorato FG; Guimarães DA; Premazzi MG; Piñeiro-Maceira JM; Bernardes-Engemann AR; Orofino-Costa R Mycoses; 2017 Sep; 60(9):587-593. PubMed ID: 28504456 [TBL] [Abstract][Full Text] [Related]
27. A 15-year retrospective study on the prevalence of onychomycosis in psoriatic vs non-psoriatic patients: A new European shift from dermatophytes towards yeast. Gallo L; Cinelli E; Fabbrocini G; Vastarella M Mycoses; 2019 Aug; 62(8):659-664. PubMed ID: 31062415 [TBL] [Abstract][Full Text] [Related]
28. Onychomycosis in Adana, Turkey: a 5-year study. Ilkit M Int J Dermatol; 2005 Oct; 44(10):851-4. PubMed ID: 16207188 [TBL] [Abstract][Full Text] [Related]
29. Mycological aspects of onychomycosis in Khuzestan Province, Iran: A shift from dermatophytes towards yeasts. Fatahinia M; Jafarpour S; Rafiei A; Taghipour S; Makimura K; Rezaei-Matehkolaei A Curr Med Mycol; 2017 Dec; 3(4):26-31. PubMed ID: 29707676 [TBL] [Abstract][Full Text] [Related]
30. Epidemiology of onychomycosis in Serbia: a laboratory-based survey and risk factor identification. Dubljanin E; Džamić A; Vujčić I; Grujičić SŠ; Arsenijević VA; Mitrović S; Čalovski IČ Mycoses; 2017 Jan; 60(1):25-32. PubMed ID: 27469902 [TBL] [Abstract][Full Text] [Related]
32. [Increasing frequency of onychomycoses--is there a change in the spectrum of infectious agents?]. Ginter G; Rieger E; Heigl K; Propst E Mycoses; 1996; 39 Suppl 1():118-22. PubMed ID: 8767283 [TBL] [Abstract][Full Text] [Related]
33. High prevalence of mixed infections in global onychomycosis. Gupta AK; Taborda VBA; Taborda PRO; Shemer A; Summerbell RC; Nakrieko KA PLoS One; 2020; 15(9):e0239648. PubMed ID: 32991597 [TBL] [Abstract][Full Text] [Related]
34. Study of onychomycosis: prevailing fungi and pattern of infection. Veer P; Patwardhan NS; Damle AS Indian J Med Microbiol; 2007 Jan; 25(1):53-6. PubMed ID: 17377354 [TBL] [Abstract][Full Text] [Related]